Health
Decrease in serum antibodies to SARS‐CoV‐2 in convalescent plasma donors over time – Wiley
Click on the article title to read more.
To the Editor
Convalescent plasma, collected from donors who have previously recovered from viral illnesses, has been used to treat patients with a variety of emerging infectious diseases. This product has become more prominent during the current COVID19 pandemic, including with the recent emergency use authorization from the Food and Drug Administration, but the longevity of SARSCoV2 antibodies in donated plasma is unknown. Historically, convalescent plasma has been used to reduce mortality in…
-
Noosa News18 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General19 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General16 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks
-
General24 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says